Our forum is experiencing technical difficulties with comments being displayed. We apologize for the inconvience.

Reply To: NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

GCS Project Home Forum Available Clinical Trials NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Reply To: NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

#4972
Helena Gvili
Participant

Dear Diane,

Thank you for your comments. Dr. Holcomb seemed more thorough to us. He mentioned the importance of testing the biopsy during the surgery. If it came back positive, he said he would have done a vaginal hysterectomy with a bag so that everything possible could be caught (without leakage from the cyst). That made sense to us.

We will look into the trials. We learned that there is one immunotherapy approved by the FDA, but we have to see what that means. The doctor will send part of the tumor to the lab to see if there are genetic mutations and what chemo/drug it may respond to.

I wish you the very best!

Helena